https://www.selleckchem.com/products/ABT-888.html
05; sensitivity 44.40%; specificity 84.20%), higher radiographic assessment of lung oedema score (RALES) on the day of starting NIV (p less then 0.009; sensitivity 70.40%; specificity 73.75%), higher length of NIV (p less then 0.014; sensitivity 48%; specificity 84.10%) and higher urea on the day of starting NIV (p less then 0.004; sensitivity 70.44%; specificity 73.72%) Conclusion NIV treatment in COVID-19 critically ill patients has a high failure rate. In addition to respiratory parameters, dyspnoea, higher RALES, higher length of NI